Mode
Text Size
Log in / Sign up
N/A N=61 Treatment

Outcomes in Rotator Cuff Repair Using Graft Reinforcement

Rotator Cuff Tear

Enrolled (actual)
61
Serious AEs
1.6%
Results posted
Jan 2015
Primary outcome: Primary: American Shoulder and Elbow Score (ASES) — 48.7; 69.4; 79.9; 85.4 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Conexa Reconstructive Tissue Matrix (Device)
Age
Adult, Older Adult · 40+ yrs
Sex
All
Sponsor
Stryker Trauma and Extremities
Primary completion
Feb 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
American Shoulder and Elbow Score (ASES)
48.7; 69.4; 79.9; 85.4; 90.4
PRIMARY
Adjusted Constant-Murley Score
45.4; 62.9; 68.7; 71.7
PRIMARY
Simple Shoulder Test (SST)
5.0; 6.4; 8.7; 9.9; 10.6
SECONDARY
Rotator Cuff Re-tear Evaluation
18.5; 16.9; 32.2; 33.9
SECONDARY
Isometric Strength
34.4; 61.9; 83.0; 78.6

Summary

The purpose of this study is to evaluate patient shoulder functional outcomes following rotator cuff repairs reinforced with a surgical mesh.

Eligibility Criteria

Inclusion Criteria

The patient:

  • is an adult male or female between the ages of 40-70 years old;
  • has repairable primary large retracted two-tendon rotator cuff tears measuring from 3 cm to 5 cm;
  • requires surgical repair of single rotator cuff (i.e. one limb);
  • has movement of the non-operative arm defined as shoulder elevation of equal to or greater than 90 degrees and is able to perform postoperative exercises;
  • is able to return for all scheduled and required study visits;
  • is able to provide written informed consent for study participation.

Exclusion Criteria

The patient:

  • has irreparable large rotator cuff tears that are found intra-operatively. Note: irreparable is defined by the inability to approximate the tendon to the tuberosity without tension;
  • has a rotator cuff tear 5cm (measured intra-operatively);
  • has a rotator cuff tear where the subscapularis tendon is disrupted/requires repair;
  • has grade 3 or 4 fatty infiltration of the rotator cuff;
  • has had prior surgical repair to the affected shoulder;
  • is American Society of Anesthesiologists (ASA) Class 4 or 5 (See Appendix I);
  • is a tobacco user; unless tobacco free 6 months prior to surgery and willing to remain tobacco free for the duration of the study.
  • has lower limb injuries requiring walking assist devices such as crutches and walkers;
  • has a known collagen disorder, including systemic lupus erythematous (SLE), rheumatoid arthritis (RA), polymyositis, scleroderma, ankylosing spondylitis, dermatomyositis, osteogenesis imperfecta or the inherited disorders of Sjogren, Larsen, Raynaud, Ehlers-Danlos or Marfan syndrome.
  • has obstacles that pose an inordinately high surgical risk, in the judgment of the certified surgeon;
  • has co-morbid factors which predispose to postoperative infection, such as insulin dependent diabetes, chronic steroid use, malnourishment, cancer, or co-existent infection;
  • has a history of alcohol abuse, illicit drug use, significant mental illness, physical dependence to any opioid, or drug abuse or addiction;
  • is enrolled or plans to enroll in another clinical trial during this study that would affect the patient's safety or results of this trial;
  • has any of the conditions identified within the labeled contraindications, i.e. sensitivity to porcine derived products or polysorbate.
  • has an inability to have a closed MRI conducted.
  • needs a re-operation for a re-tear of the rotator cuff.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01025037). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search